Alteration of hematopoiesis by RNA type C viruses (retroviruses) provides a valuable system for analysis of the target and stromal cell interactions during leukemogenesis. Inoculation in vivo of F-MuLV (1) is associated with increased pluripotential and committed erythroid stem cell proliferation (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) , with increased numbers of spleen granulocyte-macrophage progenitor cells (14) and accelerated erythropoiesis measured by iron incorporation (7) , and with changes in red blood cell volume (4, 5) . Other studies in vitro and in vivo in diffusion chambers indicate that lymphoid cells are infected by F-MuLV (15) and that F-MuLV can induce proliferation of committed erythroid progenitor BFUe of CFUe cells in the absence of their natural obligatory humoral growth factor, erythropoietin (16, 17) . Despite evidence that F-MuLV infects and alters a variety of differentiating progeny of the hematopoietic stem cell, the virus causes predominantly erythroleukemia in vivo (1). A separate helper lymphoid leukemia virus found in F-MuLV stocks induces a distinct lymphoid leukemia after a longer latency period (18) . The virusspecific requirements for toe rapid erythroleukemogenesis by F-MuL V are unknown. Recent data indicated that the SFFV genome isolated free of lymphoid leukemia virus contains cellular recombinant genetic information not found in the associated helper virus (19) (20) (21) . The target cell interactions during leukemic transformation also remain to be elucidated.
Unlike Abelson virus, which transforms lymphoid and macrophage progenitor cells, and unlike murine sarcoma viruses, which transform macrophages within 7 days of infection of freshly explanted marrow and generate continuous cell lines (22, 23) , granulocytic leukemogenesis in, vitro by F-MuLV-Arequires a longer latency period during which both hematopoietic 868 Greenberger, Newburger, Lipton, et al.
stem cell and stromal cell maintenance is essential (24, 25) . In previous studies F-MuLV-infected marrow cultures were "recharged" after 2-4 weeks with 1.0XIO' fresh marrow cells (24, 25) . Recharged marrow cultures prevented precise studies of target-cell age because stem cells of two ages and depopulation schedules from weekly feedings were present. To study age of the target cell in F-MuLV leukemogenesis in vitro, we have modified the culture method of Dexter and Testa (26) . The present studies were done with nonrecharged cultures containing marrow of uniform age and stimulated by weekly addition of hydrocortisone to generate hematopoietic stem cells for over 20 weeks.
MATERIALS AND METHODS
Mice.-NIH Swiss [N:NIH(S)] mice were obtained from the animal colonies of the National Institutes of Health, Bethesda, Maryland.
Tissue culture.-A clonal subline of the WEHI-3 BALB/c mouse monomyelocytic leukemia (27) , designated WEHI-3 clone-5, was grown in RPMI-1640 medium with 10% fetal calf serum. Seventy-two-hour supernatants were concentrated fivefold by Amicon filtration (28) and added in a 10% volume as WEHI-3 CSF to McCoy's 5-A medium (GIBCO) supplemented with the following: 2.2 g NaHC0 3/liter, 0.1 J.Lg streptomycin/liter, lOS U penicillin/liter, 2 mM L-glutamine, 16 J.Lg L-asparagine/ml, 8 J.Lg L-serine/ml, 1 mM sodium pyruvate, a mixture of 0.8% MEM-amino acids (50 times), a mixture of 0.4% MEM-nonessential amino acids (100 times), 0.6% sodium bicarbonate solution (7.5%), and 15% fetal calf serum (Flow Laboratories, Rockville, Md.) (29) .
Viruses.-F-MuLV-A was provided by Dr. Charlotte Friend (Mt. Sinai Hospital, New York, N.Y.); a stock of A-MuLV was provided by Dr. Naomi Rosenberg (Massachusetts Institute of Technology, Boston, Mass.). These viruses were prepared as described in (24) . A clonal strain of R-MuLV designated M52R was reported (30) . This virus causes lymphoid leukemia in newborn NIH Swiss mice, with a mean latency period of 30 weeks (31) . Mutants designated ts 29, ts 26, ts 25, and ts 19 derived from the M52R clonal virus stock were reported (31) . A stock of the endogenous virus designated Balb:virus-l of BALB/c mice has been reported (32) . This virus causes chronic myeloid leukemia in newborn NIH Swiss mice, with a mean latency period of 48 weeks (32) .
Pseudotype viruses containing the SFFV genome with an R-MuLV (M52R), hereafter designated WT helper virus coat or a helper derived from each ts mutant, were prepared by infection at 31 ° C of 2.0 J.Lg polybrene/ml-pretreated (33), exponential-phase cultures of SFFV-Balb/3T3 non producer cells (1902B Balb clone 4) (34) provided by Dr. David Troxler (National Cancer Institute, Bethesda, Md.).
Virus assays.-Viruses were standardized by reverse transcriptase assay (30) of serial tenfold dilutions titered on NIH/3T3 cells at 31 ° C to lOS PIU 10.1 ml (30) ; for viruses other than Balb:virus-l we also used the XC plaque-forming assay (35) . The virus was either diluted in serum-free Dulbecco's modified Eagle's MEM or concentrated by 100,000Xg ultracentrifugation for 30 minutes.
Long-term bone marrow cultures.-The contents of both a mouse femur and tibia were flushed via a 22-gauge needle into each 1O.0-ml (Corning) plastic flask in a total of 10,0 ml Fisher's medium (GIBCO) supplemented with 25% horse serum (Flow Laboratories) (36, 37) and 10-' M hydrocortisone sodium hemisuccinate (Solu-Cortef; Upjohn, Kalamazoo, Mich.). Hydrocortisone reconstitution of horse serum stimulates and maintains both hematopoietic stem cell proliferation and marrow fat cell differentiation in vitro (36) . Fresh corticosteroid reconstitution is critical for maintained hematopoiesis (36, 37) . Cultures were incubated at 31, 33, or 37° C in 7% CO 2 . Medium was changed and depopulated by weekly removal of non adherent cells and replacement with 10.0 ml fresh 10-7 M corticosteroid-containing medium. Cultures were not recharged with any additional marrow. Initial inocula were 2.0±0.3XIO' cells for (30-33 g> adult marrow and 0.8±0.5XlO' cells for lO-day-old mouse marrow cultures. Virus was added at the time of initiation, except where otherwise indicated, by addition of lOS or 10 4 PIU of each virus in 0.1 ml serum-free Dulbecco's modified Eagle's MEM. Cultures infected at initiation were maintained in 2.0 ml shallow monolayer for 2 hours followed by addition of 8.0 ml medium, Cultures infected at other times received the 0.1 ml virus volume simultaneously with medium change.
Cultures were initiated in 25% horse serum (Flow Laboratories) with 10-' M hydrocortisone but were switched at day 28 to weekly feeding with medium containing 25% fetal calf serum (Flow Laboratories) with 10-7 M hydrocortisone. Equivalent hematopoiesis in the absence of lipogenesis in corticosteroid-supplemented fetal calf serum has been reported (38) . Substitution of calf serum for horse serum increases virus proliferation and prolongs adherence of hematopoietic cell islands (38) . These conditions maintain marrow hematopoiesis for periods longer than previously reported (25, 26) .
Hematopoietic cell colony-forming assays.-Cells removed weekly from marrow cultures were assayed for number of progenitor CFUc (39) by transfer of 1.0XlO s or 5.0X10 4 cells to 1.0-ml cultures containing McCoy's 5-A medium supplemented with 10% WEHI-3 CSF and 0.3% agar (Bacto agar; Difco). Cultures were incubated at 37° C; on day 7 we scored clusters containing 10-49 cells and colonies containing 50 or more cells under a Unitron inverted microscope. Individual colonies were removed from agar at 7 days and were then stained for MPO, for specific "myeloid" esterase activity (esterase-M) (ASD substrate specific), for hemoglobin with the use of benzidine, for lysozyme by means of immunofluorescence, or with Wright's-Giemsa (40) . Other agar cultures containing 1.0XlO s or 5.0X10 4 cells were grown in the absence of added CSF. CFUL were assayed in 0.3% agar (Difco Laboratories) supplemented with 15% fetal calf serum, 100 J.Lg LPS/ml, and 10 7 sheep red blood cells (CFVL). CFVL scored as colony numbers on day 7 were those inhibjted in parallel cultures containing also a O.l-ml volume of a I :50 dilution of goat antimouse immunoglobulin antiserum (Litton Bionetics, Kensington, Md.) (29) . This antiserum concentration inhibited less than I % of CFVc colonies grown in WEHI-3 CSF.
BFVe and CFVe cells were scored by addition of 0.1 ml of cell suspensions to 0.8 ml of the erythropoietindependent plasma clot incubation system described by McLeod and co-workers (41) as modified by Clarke and Housman ~42). The final cell concentrations/ml of clot were 5XlO -10 6 / m l. Erythropoietin was derived from human urine (partially purified and provided by Dr. Peter Dukes, Hematology Research Laboratories, Children's Hospital of Los Angeles, Los Angeles, Calif.) to a specific activity of approximately 50 IV protein/mg). Studies were performed at erythropoietin concentrations that produced maximal colony numbers in control samples (2 IV erythropoietin/ml). Clotting was induced with 0.1 ml NCTC 109 (Microbiological Associates, Bethesda, Md.) containing I V of grade I bovine thrombin (Sigma Chemical Co., St. Louis, Mo.) This was added to 0.9 ml of the cell incubation system. Then O.IO-ml samples of the clotting mixture were rapidly dispensed into 0.2-ml Microtiter culture wells (Linbro Chemical Co., New Haven, Conn.) and incubated under 5% C02 in high humidity at 37° C.
The plasma clots were incubated up to 7 days. On days 2, 4, and 7, groups of identical clots were fixed and stained for hemoglobin as described by McLeod and co-workers (41) . Peak EC growth for cell suspension removed from marrow cultures was at 4 days, with no appearance of later colonies. In experiments reported here, growth was diffuse when occurring and designation of colony size as CFVe (4-8 cells) (24) , and each subclonal line was passaged two times per week for an additional 100 days.
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Tumorigenicity studies.-Cells were inoculated ip into I-day-old newborn NIH Swiss mice or iv by tail vein into NIH Swiss mice (30-33 g each) and mice were studied for evidence of leukemogenesis (24) .
Histochemical staining and lysozyme determination.-Glass cover slip smears were stained with Wright's-Giemsa or tested with cytochemical methods for myeloperoxidase (40) and esterase-M with ASD substrate (40) . Leukocyte alkaline phosphatase activity was evaluated by the cobalt chloride method and a method that measured azo dye precipitated by anaphthol released by enzyme action on a-naphthol phosphate substrate (40) . This method has been shown to correlate with biochemical quantitation of enzyme (44, 45) .
For lysozyme measurement, cells were pelleted by centrifugation and lXIO s to lXlO 7 cells were resuspended in RPMI-1640 serum less medium (GIBCO) and placed in 0.3-ml volume wells of the lysoplate assay (46) . Tissue culture medium was harvested after growth periods of 24, 48, or 72 hours of I. OX lOS to I. OX 10 7 cells/ml and was also assayed in lysoplates. Lysoplates were scored at 18-24 hours and compared to a standard curve with a purified rat lysozyme standard (47) . An immunofluorescent microscopic assay with rabbit F(ab'h antilysozyme antiserum prepared against rat lysozyme (47) was also performed.
Measurement of superoxide generation.-We used a continuous spectrophotometric assay of superoxide dismutase-inhibitable cytochrome c reduction after stimulation of cells by phorbol myristate acetate (48) (49) (50) according to procedures in (23) . Concurrent positive controls were run with normal mouse granulocytes harvested from the peritoneal cavity after casein injection (51) .
RESULTS

Generation of Permanent Granulocytic Leukemia Cell Lines by F-MuLV-A In Vitro
Leukemogenesis in vivo by F-MuLV-A occurs more rapidly in newborn compared to adult mice. To determine whether this was attributable to an agemodulated susceptibility of hematopoietic stem cells to virus, we infected marrow cultures from adult (l yr old) or lO-day-old suckling mice at the time of initiation with F-MuLV-A. As shown in table 1, each of eight cultures (A-H) of adult marrow generated at week 4 (day 28) increased nonadherent cell numbers and immature granulocytic cells compared to uninfected control cultures (Q-S). Cell number increases were detected with lOS pru and a lower virus titer (l0 4 PIV) (E-H). Total cells removed were elevated compared to control cultures through week 12 (day 84), with gradual decrease by day 112. F-MuLV-A-infected adult marrow cultures had run down by 20 weeks (day 140); however, total cell numbers generated were still higher than those in control cultures. These data confirmed and extended the observations of Dexter et al. (25) and our previous studies (24) with the use of a The contents of a single femur and tibia were flushed into plastic flasks as described in "Materials and Methods" on day 0, and medium was changed by removal of the entire flask volume each wk and replacement with 10 ml fresh medium containing 25% horse serum and 10-7 M hydrocortisone sodium hemisuccinate. Fetal calf serum was substituted for horse serum weekly from day 21. All cultures were kept at 33° C in 7% CO2• b F-MuLV-A containing Hf PIU in 1.0 ml was added to each indicated culture at time of initiation (day 0). Cultures receiving 10' PIU received 0.1 ml of virus and 0.9 ml additional medium.
-Generation of granulocytic leukemia cell lines in nonrecharged continuous long-term bone marrow cultures
< Total cells removed in the lO-ml weekly harvested volume were counted and then Wright's-Giemsa-stained glass cover slip smears scored for percent immature cells (myeloblasts, promyelocytes, and myelocytes). The number of immature cells was then calculated by the multiplication of the total cell count by this percent. NT = not tested.
d Weekly harvested cells after cell count and cover slip preparation were assayed for number of CFUc, CFUL, BFUe cells, CFUe cells, and CFUs cells/lO s cells (see table 2) or were centrifuged to a pellet and resuspended in McCoy's 5-A medium supplemented with the reagents described in "Materials and Methods" and with 10% dialyzed WEHI-3 CSF. These suspension cultures were transferred to plastic flasks at 37° C (7% in CO2) and subcultured every 3 or 4 days. A culture "establishing" a permanent cell line is defined as showing continuous subculture for 70 days and ability to sustain passage at 10' cells/10.0 ml. recharged mouse marrow cultures. Nonadherent cells removed as early as day 28 from F-MuLV-A-infected cultures proliferated at 37° C in secondary suspension cultures and generated permanent cell lines (four of eight cultures, table I). All adult marrow cultures by day 49 had produced secondary suspension cultures that generated permanent cell lines.
To determine whether marrow from younger mice would generate stably transformed cell lines faster, we established femur and tibial marrow from 10-day-old suckling mice in long-term culture. Cell numbers removed at days 28, 56, and 84 from F-MuLV-Ainfected suckling cultures were not detectably higher than those removed from F-MuLV-A-infected adult cultures, and leukemia lines were generated at similar time intervals (five of eight by day 28; eight of eight by day 49) (table I). Sixteen cultures of 20-day fetal NIH Swiss mouse marrow did not further decrease this time requirement (first cell lines were generated at day 28; all were leukemic by day 49). Thus a minimum latency period of 28 days' at 33° C with 7% CO 2 
Effect of Cumulative Hematopoietic Stem Cell Depopulation of Marrow Cultures on LeUkemogenesis
To determine whether the 28-day latency period for generation of stably transformed cell lines reflected a time required for establishment of the in vitro hematopoietic microenvironment (26), we designed the following experiment. Forty adult NIH Swiss marrow cultures were established as above, and 10 5 PIU of FMuLV-A was added to each of 4 groups of eight cultures at days 0, 14, 56, or 84. Eight cultures were uninfected. Nonadherent cells removed from cultures weekly were transferred as described in "Materials and Methods" for growth in secondary suspension cultures. All culture supernatants were reverse transcriptasepositive within 14 days of addition of F-MuLV-A.
As shown in text-figure I, addition of virus at day 14 produced the same magnitude of cell proliferation . , infected at wk 2; . , infected at wk 8; e, infected at wk 12. compared to that in cultures infected at day O. In contrast. cultures infected at later times. day 56 or 84. did not demonstrate as great a proliferative response. There was a low but clear increase in cell numbers removed at day 112 (wk 16) from cultures infected at week 8 compared to the level seen in uninfected cultures; however. these removed cells were not comparably shifted to immature morphology and did not grow continuously in secondary suspension cultures. Nonadherent cells removed from each group of cultures were examined for persistent in vitro growth in secondary suspension cultures and for ability to generate clonal permanent transformed cell lines.
As shown in text-figure 1. nonadherent cells from each of eight cultures infected at day 0 and tested at day 56 (wk 8) generated permanent cell lines. Four of these eight cultures generated cell lines as early as day 28 (wk 4). Cells removed· from these same cultures at later times failed to generate permanent cell lines: 0 of
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The removed cells at weeks 16 and 20 contained more differentiated granulocytes compared to those removed from the same cultures at earlier times after infection (table 1) .
Cells removed at day 28 (wk 4) from each of eight cultures infected at day 14 (wk 2) were not established as permanent cell lines (text- fig. 1 ), whereas two of eight cultures did generate cell lines by day 56 (wk 8 
Biologic Properties of Cells Removed From F-MuLV-A-lnfected Primary Marrow Cultures and Derived Permanent Leukemia Lines
Nonadherent cells from primary marrow cultures were tested after F-MuLV-A infection for biologic responsiveness to known humoral stimuli of in vitro differentiation and for spleen colony-forming ability in the CFUs cell assay. Inasmuch as the F-MuLV-A stock is heterogeneous (34), a cloned SFFV genome was rescued from SFFV non producer Balb/3T3 clone A31 cells with a clonal R-MuLV helper virus and this virus, designated SFFV (R-MuL V), also was tested. Cultures infected with R-MuLV (WT) helper virus and uninfected control cultures were also established.
As shown in table 2, CFUc per 5XI0 4 non adherent cells persisted at 86-251 colonies over 20 weeks, with a gradual decrease between weeks 8 and 20. CFUs cells were detected to week 12. In contrast, there were no detectable BFUe or CFUe cells after 56 days in control or virus-infected cultures. CFUe cell clusters were detected at days 7, 14, and 28 but disappeared thereafter. Larger BFUe cells were detected through day 28 but were also not detected by day 56. CFUL were never detected during the 20-week period.
Morphologic examination of individual CFUc colonies removed from agar culture revealed granulocyte and macrophage morphology. Other CFUc cultures were grown in 0.3% agar supplemented with a O.l-ml volume of a 1:50 dilution of goat antimouse immunoglobulin antiserum (29 f Colonies were scored at day 9 after inoculation of 10 5 cells iv as described in "Materials and Methods." Numbers of background colonies from uninoculated but irradiated mice are subtracted. Values are means±SE for 10 spleens for each sample. Only colonies > 1 mm in diameter. were scored as CFUs derived.
, Each cell line was tested after at least 100 days' passage twice a week in suspension culture. Number of colonies forming spontaneously in agar alone was subtracted (1(}-112/10 tures of these nonadherent cells showed macrophage and granulocyte terminal differentiation within 2-3 weeks at 37° C.
Permanent cell lines established from 28-or 35-dayold nonadherent cell harvests from F-MuLV-A-or SFFV (R-MuLV)-infected cultures were cloned as described in "Materials and Methods" and tested for colony formation in semisolid medium after at least 100 days' growth in suspension culture at 37° C. As shown in table 2 cells. Growth of these cells in liquid medium for 24 hours was associated with release of lysozyme into the medium. Nonadherent cells from control or virusinfected cultures generated superoxide following stimulation with phorbol myristate acetate to a level approximately one-third that of normal mouse polymorphonuclear leukocytes. Cells in control cultures at days 28 and 84 were composed of 80% or more mature leukocytes: polymorphonuclear leukocytes, band forms, and metamyelocytes.
Histochemical and Biochemical Properties of Nonadherent Cells From Primary Marrow Cultures and Derived Permanent Cell Lines
Permanent cell lines were tested for persistence of the above biochemical markers. As shown in table 3, esterase-M, MPO, and lysozyme were synthesized by FMuLV-D, F-MuLV-A, SFFV (R-MuLV) #6-7, and AMuLV (M-MuLV) III cell lines; however, there was no detectable superoxide generation. Cell lines tested over a 4-month period remained negative for superoxide. Thus one functional marker of granulocytic macrophage differentiation was lost during establishment of permanent cell lines, whereas other markers were maintained. Cell lines listed in table 3 maintained greater than 80% immature promyelocyte or myeloblast morphology over a lO-month period with subculture every 3-4 days. " Weekly cell harvests were prepared as described in table 1. b Cell preparations were assayed for the percent of 1,000 cells in each of duplicate preparations that were positive for ASD substratespecific esterase, MPO, and leukocyte alkaline phosphatase (LAP). [Mouse marrow cells were negative for LAP, and W/F rat marrow was used as a positive control (40) . ] , Cells pelleted by centrifugation were resuspended in 0.2 ml of serum-free Fisher's medium containing 1.0X10' cells and placed in O.2-ml wells of the lysoplate assay. Duplicate cell pellets were incubated for 24 hr in 1.0 ml Fisher's medium and then cell-free supernatants were assayed by the lysoplate procedure. Results are expressed as /-lg lysozyme activity scored at 20 hr according to procedures in (46) .
d Cell pellets containing 10 7 cells were assayed for superoxide-generating capacity following stimulation with phorbol myristate acetate according to procedures in (23) . Results are the mean of three determinations for each sample.
, Polymorphonuclear leukocytes, bands, metamyelocytes, and monocyte-macrophages.
Generation of Granulocytic Leukemia Cell Lines at 31 0 C by ts Mutant Helper Virus Pseudotypes of SFFV
Mutants of R-MuL V that are ts, with growth restricted to 310 C, have been isolated (30) . In particular, two classes have been defined: 1) those defective in early post-penetration replication steps (ts 19 and ts 29) and 2) a distinct class defective in late stages of replication (ts 25 and ts 26). The second class of mutants is capable of synthesizing proviral DNA and integrating this copy into the cellular genome such that Kirsten murine sarcoma virus pseudotypes of ts 25 or ts 26 will infect and transform fibroblasts at 37 0 C, the non permissive temperature for replication.
To determine whether leukemogenesis by SFFV would occur in the absence of a replicating helper virus, we established NIH Swiss mouse marrow cultures at both 31 and 37 0 C and infected them with each of the following viruses prepared as described in "Materials and Methods": SFFV (ts 29, ts 26, ts 25, or ts 19); SFFV (R-MuLV) WT; ts 29, ts 26, ts 25, or ts 19; and R-MuLV WT. Other cultures were maintained at each temperature without virus infection.
As shown in text- figure 2A , uninfected control cultures at 37 0 C showed rapid decrease in numbers of nonadherent cells generated compared to cultures maintained at 33 0 C (text- fig. 1) or at 31 0 C (text-fig.  2B ). These results indicated that higher temperature decreased the duration of hematopoiesis in vitro in long-term marrow cultures; thus previous studies by Dexter and Testa (26) were confirmed.
Infection of cultures at 37 0 C with SFFV (R-MuLV) increased cell proliferation and generated permanent cell lines in four of four cultures by day 58 (wk 8) (text- fig. 2A ). Similarly, eight of eight cultures at 31 0 C infected with this virus showed increased cell proliferation and generated permanent cell lines (text- fig. 2B ). The duration of the increased proliferative response to virus was longer at the lower temperature. Infection with R-MuL V WT helper virus alone produced a detectable increase in cell proliferation in cultures at 37 or 31 0 C with prolonged hematopoiesis in those cultures compared to control cuJtures; however, no cell lines were generated. Addition of SFFV (ts 26) or ts 26 helper virus alone to cultures (37 0 C) produced no detectable effect on cell proliferation (text- fig. 2A ). In striking contrast, infection of cultures (31 0 and myeloblasts with low numbers (1-3%) of morphologically mature granulocytes. Several clonal cell lines derived from the parent suspension cultures were inoculated ip into newborn or iv by tail vein into adult mice (30-33 g each). Mice receiving 10 7 control culture nonadherent cells did not develop leukemia or any evidence of disease during the 100-day observation period. In contrast, newborn or adult mice receiving cell line SFFV (ts 29) #15, SFFV (ts 26) #12, SFFV (RMuLV) #81, or SFFV (R-MuLV) #6-7 developed fatal leukemia with elevated peripheral blood leukocyte counts by 30 days and 30-93% blast cells on differential cell counts (no blasts detected in controls).
Cell-free, Millipore-filtered supernatants from cultures of each permanent cell line were harvested from dense 72-hour cultures containing I.OXI0 7 cells/ml, were concentrated 100-fold by ultracentrifugation, and were inoculated into newborn or adult NIH Swiss mice. Mice receiving cell-free supernatants from the FMuLV -D cell line developed significant splenomegaly and erythroleukemia with a mean latency period of 43 days. Similar results were obtained with virus recovered from SFFV (R-MuLV) #81 cell line. In striking contrast, the cell-free supernatant from cell line SFFV (ts 29) #15 harvested at 31° <;: and containing elevated reverse transcriptase activity (153 pmol [3H]TMP incorporated/ml) did not induce any detectable disease in vivo, nor did representative mice killed after 100 days of virus inoculation demonstrate splenomegaly or virus release from freshly explanted normal-appearing bone marrow or spleen cells.
DISCUSSION
In the present studies we have defined several cellular and viral requirements for in vitro granulocytic leukemogenesis in long-term bone marrow cultures by F-MuLV. Unlike studies by Dexter et al. (25) and ours (24), cultures were not recharged with additional marrow so that cells of uniform age would be studied over 24 weeks' growth in vitro as in (53) . F-MuLV leukemogenesis was detected after addition of virus to early cultures (wk 1-4) but not to late cultures (wk 8, 12, 16), though comparable evidence of virus infection and numbers of CFUc were generated. Leukemogenesis by F-MuLV required a minimum of 28 days in 31 or 33° C cultures in the hematopoietic microenvironment of the primary culture with persistent virus replication. Cells removed from primary marrow cultures before day 28 and transferred to secondary suspension cultures did not establish cell lines, whereas those removed after day 28 but before day 112 established continuous suspension cell lines that could be cloned in semisolid medium and continually passaged.
The failure of cell lines to be generated from nonadherent cells harvested from F-MuLV-A-infected primary cultures after day 112 suggested several possible mechanisms: I) the formation of an inhibitory microenvironment (perhaps due to macrophage overgrowth) (26, 37) ; 2) absence of susceptible target cells through weekly removal; and 3) target cell differentiation to an un susceptible compartment. That the first explanation was not the case was indicated by experiments which revealed return of leukemogenic capacity if fresh cells were added to late cultures. Other studies from this laboratory (Mauch P, Greenberger JS, Botnick LE, Hannon E, Hellman S: Manuscript in preparation) have demonstrated heterogeneity of the stem cells generated in our unrecharged marrow cultures and cells with the greatest self-renewal potential detected in the adherent component of early cultures. These data taken together suggest that the target cell for transformation by F -MuLV is an "early" hematopoietic stem cell with an intrinsically high self-renewal potential. This target cell appears to require other cells in the adherent component of the marrow cultures during several weeks of virus replication before non adherent cells are generated that can sustain continuous passage in secondary suspension cultures.
Virus-specific requirements for F-MuLV leukemogenesis were also partially elucidated. Helper virus replication was required in primary marrow cultures during the 28 days after infection. This was shown by infection of cultures with ts helper virus mutant pseudotypes of the SFFV genome rescued from SFFVBalb/3T3 clone A31 non producer cells. At 31° C, ts viruses or R-MuLV WT virus alone induced an increase in numbers of CFUc generated but did not produce permanent cell lines. In contrast, ts-mutant pseudotypes of SFFV produced both increases in CFUc and generated permanent cell lines. Neither effect was observed following ts helper virus or ts pseudotype virus infection of cultures at 37° C. Thus helper virus replication was clearly associated with granulocytic cell proliferation and increased longevity of the cultures (37); however, complete transformation (generation of leukemia cell lines) required additional viral gene function(s) not present in helper virus alone. These function(s) were supplied by SFFV or a virus in our FMuLV -A stock. Evidence that the viral function(s) required for complete transformation are those of SFFV is supported by our observations of: 1) SFFV activity in our F-MuLV-A stock passaged once through newborn NIH Swiss mice and 2) persistent release of biologically detectable SFFV from clonally derived F-MuLV-A-induced permanent cell lines after over 1 year's continuous passage in suspension culture (Greenberger JS, Eckner RJ, Ostertag W, et al: Manuscript in preparation). The origin of the SFFV in our F-MuLV-A stock is uncertain but may have been derived during virus passage in NIH Swiss mice.
In other transformation studies with F-MuLV in vitro, a B6D2F I mouse cell line was derived from FMuLV-P-infected long-term marrow cultures but the established cell line released only the late lymphoid leukemia virus (54) . Similar results were obtained with erythroleukemia or macrophage cell lines derived from DBA/2 mouse fetal liver or bone marrow cultures infected with F-MuLV-A or F-MuLV-P, respectively (55, 56) . The virus released from our present and previous (24) granulocytic cell lines after over I year's passage in vitro continues to induce erythroleukemia in vivo in adult or newborn mice and has SFFV activity. Experiments are in progress to further analyze the role of SFFV and other associated virus(es) of the FMuLV complex in leukemogenesis in vitro.
